Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Croft

Showing results (131-140 of 182) with videos related to

Pageof 19
Sort By:
American Journal of Clinical Dermatology|January 18, 2024
OX40 in the Pathogenesis of Atopic Dermatitis-A New Therapeutic TargetMichael Croft, Ehsanollah Esfandiari, Camilla Chong, et al.
European Journal of Immunology|April 26, 2013
Transgenic expression of survivin compensates for OX40-deficiency in driving Th2 development and allergic inflammationFengyang Lei, Jianyong Song, Rizwanul Haque, et al.
American Journal of Clinical Dermatology|February 10, 2024
Correction to: OX40 in the Pathogenesis of Atopic Dermatitis-A New Therapeutic TargetMichael Croft, Ehsanollah Esfandiari, Camilla Chong, et al.
Science Immunology|November 19, 2021
TWEAK functions with TNF and IL-17 on keratinocytes and is a potential target for psoriasis therapyRinkesh K Gupta, Donald T Gracias, Daniela Salgado Figueroa, et al.
The Journal of Allergy and Clinical Immunology|June 24, 2015
Rhinovirus infection interferes with induction of tolerance to aeroantigens through OX40 ligand, thymic stromal lymphopoietin, and IL-33Amit K Mehta, Wei Duan, Astrid M Doerner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2007
OX40 costimulation promotes persistence of cytomegalovirus-specific CD8 T Cells: A CD4-dependent mechanismIan R Humphreys, Andrea Loewendorf, Carl de Trez, et al.
The Journal of Clinical Investigation|July 28, 2007
SLAT regulates Th1 and Th2 inflammatory responses by controlling Ca2+/NFAT signalingStéphane Bécart, Céline Charvet, Ann J Canonigo Balancio, et al.
International Immunology|December 24, 2005
Combined CD137 (4-1BB) and adjuvant therapy generates a developing pool of peptide-specific CD8 memory T cellsLara Myers, Seung Woo Lee, Robert J Rossi, et al.
The British Journal of Dermatology|June 5, 2024
The role of OX40 ligand/OX40 axis signalling in atopic dermatitisEmma Guttman-Yassky, Michael Croft, Bob Geng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 18, 2016
Aging Converts Innate B1a Cells into Potent CD8+ T Cell InducersCatalina Lee-Chang, Monica Bodogai, Kanako Moritoh, et al.
Pageof 19

Showing results (131-140 of 182) with videos related to

Sort By:
Pageof 19
American Journal of Clinical Dermatology|January 18, 2024
OX40 in the Pathogenesis of Atopic Dermatitis-A New Therapeutic TargetMichael Croft, Ehsanollah Esfandiari, Camilla Chong, et al.
European Journal of Immunology|April 26, 2013
Transgenic expression of survivin compensates for OX40-deficiency in driving Th2 development and allergic inflammationFengyang Lei, Jianyong Song, Rizwanul Haque, et al.
American Journal of Clinical Dermatology|February 10, 2024
Correction to: OX40 in the Pathogenesis of Atopic Dermatitis-A New Therapeutic TargetMichael Croft, Ehsanollah Esfandiari, Camilla Chong, et al.
Science Immunology|November 19, 2021
TWEAK functions with TNF and IL-17 on keratinocytes and is a potential target for psoriasis therapyRinkesh K Gupta, Donald T Gracias, Daniela Salgado Figueroa, et al.
The Journal of Allergy and Clinical Immunology|June 24, 2015
Rhinovirus infection interferes with induction of tolerance to aeroantigens through OX40 ligand, thymic stromal lymphopoietin, and IL-33Amit K Mehta, Wei Duan, Astrid M Doerner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2007
OX40 costimulation promotes persistence of cytomegalovirus-specific CD8 T Cells: A CD4-dependent mechanismIan R Humphreys, Andrea Loewendorf, Carl de Trez, et al.
The Journal of Clinical Investigation|July 28, 2007
SLAT regulates Th1 and Th2 inflammatory responses by controlling Ca2+/NFAT signalingStéphane Bécart, Céline Charvet, Ann J Canonigo Balancio, et al.
International Immunology|December 24, 2005
Combined CD137 (4-1BB) and adjuvant therapy generates a developing pool of peptide-specific CD8 memory T cellsLara Myers, Seung Woo Lee, Robert J Rossi, et al.
The British Journal of Dermatology|June 5, 2024
The role of OX40 ligand/OX40 axis signalling in atopic dermatitisEmma Guttman-Yassky, Michael Croft, Bob Geng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 18, 2016
Aging Converts Innate B1a Cells into Potent CD8+ T Cell InducersCatalina Lee-Chang, Monica Bodogai, Kanako Moritoh, et al.
Pageof 19